Insider Trading & Ownership of Stephen A. Sherwin

Location
San Diego, CA
Summary
The estimated net worth of Stephen A. Sherwin is at least $3,451,155 dollars as of 03 Sep 2025. Stephen A. Sherwin is the Director of BIOGEN INC. and owns shares of BIOGEN INC. (BIIB) stock worth about $1.74M. Stephen A. Sherwin is the Director of NEUROCRINE BIOSCIENCES INC and owns shares of NEUROCRINE BIOSCIENCES INC (NBIX) stock worth about $1.72M.
Signature
/s/ Darin Lippoldt, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Stephen A. Sherwin and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Quick Takeaways

  • Stephen A. Sherwin has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $3,451,155.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: BIOGEN INC. ($1,735,912).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Stephen A. Sherwin

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BIIB BIOGEN INC. Director $1,735,912 17 Jun 2025
NBIX NEUROCRINE BIOSCIENCES INC Director $1,715,243 02 Sep 2025
BIOS BioPlus Acquisition Corp. Director 02 Dec 2021
EPHY Epiphany Technology Acquisition Corp. Director 16 Sep 2022

Insider Transactions Reported by Stephen A. Sherwin:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .